Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Adam

Showing results (991-1000 of 1,391) with videos related to

Pageof 140
Sort By:
Journal of the American Chemical Society|August 2, 2013
H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapyEric W Price, Brian M Zeglis, Jacqueline F Cawthray, et al.
Clinical Medicine (London, England)|October 3, 2015
Experience from two decades of the Cambridge Rapid Access Neurology ClinicLaura T Axinte, Barnaby D Fiddes, Alastair Donaghy, et al.
Diagnostic Microbiology and Infectious Disease|February 20, 2018
PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium difficile Surveillance Study (CAN-DIFF) 2013-2015James A Karlowsky, Heather J Adam, Tyler Kosowan, et al.
Health Technology Assessment (Winchester, England)|March 24, 2010
Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trialA W Bradbury, D J Adam, J Bell, et al.
Journal of Inflammation Research|September 30, 2021
Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and MeditationRyan D Castle, Michelle A Williams, William C Bushell, et al.
Journal of the American Chemical Society|October 21, 2010
Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaborationEszter Boros, Cara L Ferreira, Jacqueline F Cawthray, et al.
Journal of Experimental Psychology. Human Perception and Performance|June 17, 1998
Effects of age on performance in a finger-precuing taskJ J Adam, F G Paas, J C Teeken, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Increasing rates of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Canadian Hospitals: 17 years of the CANWARD study, 2007-23Philippe Lagacé-Wiens, Laura Mataseje, Melissa McCracken, et al.
Journal of the American Medical Directors Association|March 30, 2013
Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with agingMarika Leenders, Lex B Verdijk, Letty van der Hoeven, et al.
International Journal of Antimicrobial Agents|April 30, 2019
In vitro susceptibility of urinary Escherichia coli isolates to first- and second-line empirically prescribed oral antimicrobials: CANWARD surveillance study results for Canadian outpatients, 2007-2016James A Karlowsky, Philippe R S Lagacé-Wiens, Heather J Adam, et al.
Pageof 140

Showing results (991-1000 of 1,391) with videos related to

Sort By:
Pageof 140
Journal of the American Chemical Society|August 2, 2013
H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapyEric W Price, Brian M Zeglis, Jacqueline F Cawthray, et al.
Clinical Medicine (London, England)|October 3, 2015
Experience from two decades of the Cambridge Rapid Access Neurology ClinicLaura T Axinte, Barnaby D Fiddes, Alastair Donaghy, et al.
Diagnostic Microbiology and Infectious Disease|February 20, 2018
PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium difficile Surveillance Study (CAN-DIFF) 2013-2015James A Karlowsky, Heather J Adam, Tyler Kosowan, et al.
Health Technology Assessment (Winchester, England)|March 24, 2010
Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trialA W Bradbury, D J Adam, J Bell, et al.
Journal of Inflammation Research|September 30, 2021
Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and MeditationRyan D Castle, Michelle A Williams, William C Bushell, et al.
Journal of the American Chemical Society|October 21, 2010
Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaborationEszter Boros, Cara L Ferreira, Jacqueline F Cawthray, et al.
Journal of Experimental Psychology. Human Perception and Performance|June 17, 1998
Effects of age on performance in a finger-precuing taskJ J Adam, F G Paas, J C Teeken, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Increasing rates of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Canadian Hospitals: 17 years of the CANWARD study, 2007-23Philippe Lagacé-Wiens, Laura Mataseje, Melissa McCracken, et al.
Journal of the American Medical Directors Association|March 30, 2013
Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with agingMarika Leenders, Lex B Verdijk, Letty van der Hoeven, et al.
International Journal of Antimicrobial Agents|April 30, 2019
In vitro susceptibility of urinary Escherichia coli isolates to first- and second-line empirically prescribed oral antimicrobials: CANWARD surveillance study results for Canadian outpatients, 2007-2016James A Karlowsky, Philippe R S Lagacé-Wiens, Heather J Adam, et al.
Pageof 140